연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
2437. Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance
Kim HS, Han Y, Kang JS, Choi YJ, Byun Y, Kim H, Lee KB, Kim H, Kwon W, Jang JY
Ann Surg. 2020 Sep 15.
Link
2436. Risk prediction for malignant intraductal papillary mucinous neoplasm of the pancreas: logistic regression versus machine learning
Kang JS, Lee C, Song W, Choo W, Lee S, Lee S, Han Y, Bassi C, Salvia R, Marchegiani G, Wolfgang C, He J, Blair AB, Kluger M, Su G, Kim SC, Song KB, Yamamoto M, Higuchi R, Hatori T, Yang CY, Yamaue H, Hirono S, Satoi S, Fujii T, Hirano S, Lou W, Hashimoto Y, Shimizu Y, Del Chiaro M, Valente R, Lohr M, Choi DW, Choi SH, Heo JS, Motoi F, Matsumoto I, Lee WJ, Kang CM, Shyr YM, Wang SE, Han HS, Yoon YS, Besselink M, Huijgevoort N, Sho M, Nagano H, Kim SG, Honda G, Yang Y, Yu HC, Yang JD, Chung JC, Na
Sci Rep
. 2020 Nov 18;10(1):20140.
Link
2435. Risk Factors for Recurrence in Pancreatic Neuroendocrine Tumor and Size as a Surrogate in Determining the Treatment Strategy: A Korean Nationwide Study
Kwon W, Jang JY, Song KB, Hwang DW, Kim SC, Heo JS, Choi DW, Hang HK, Kang CM, Yoon YS, Han HS, Park JS, Hong TH, Cho CK, Ahn KS, Lee H, Lee SE, Jeong CY, Roh YH, Kim HJ
Neuroendocrinology.September 28, 2020
Link
2434. A comparison of outcomes in patients withintracholecystic papillary neoplasms or conventionaladenocarcinomas of the gallbladder
Kang JS, Lee KB, Choi YJ, Byun Y, Han Y, Kim H, Kwon W, Jang JY
HPB (Oxford)
. 2020 Oct 19;S1365-182X(20)31155-2.
Link
2433. Preoperative Carbohydrate Antigen 19‐9 and Standard Uptake Value of Positron Emission Tomography‐Computed Tomography as Prognostic Markers in Patients with Pancreatic Ductal Adenocarcinoma
Moon D, Kim H, Han Y, Byun Y, Choi Y, Kang J, Kwon W, Jang JY
J Hepatobiliary Pancreat Sci. 2020 Oct 15.
Link
2432. Optimal stapler cartridge selection to reduce post-operative pancreatic fistula according to the pancreatic characteristics in stapler closure distal pancreatectomy
Kang MK, Kim H, Byun Y, Han Y, Choi YJ, Kang JS, Kwon W, Han IW, Shin SH, Choi DW, You Y, Heo JS, Jang JY
HPB (Oxford). 2020 Oct 2;S1365-182X(20)31147-3.
Link
2431. Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study
Kwon W, Kim H, Han Y, Hwang YJ, Kim SG, Kwon HJ, Vinuela E, Járufe N, Roa JC, Han IW, Heo JS, Choi SH, Choi DW, Ahn KS, Kang KJ, Lee W, Jeong CY, Hong SC, Troncoso AT, Losada HM, Han SS, Park SJ, Kim SW, Yanagimoto H, Endo I, Kubota K, Wakai T, Ajiki T, Adsay NV, Jang JY
Br J Surg
. 2020 Sep;107(10):1334-1343.
Link
2430. Biomarker Panel for the Diagnosis of Pancreatic Ductal Adenocarcinoma
Kim H, Kang KN, Shin YS, Byun Y, Han Y, Kwon W, Kim CW, Jang JY
Cancers (Basel). 2020 Jun; 12(6): 1443.
Link
2429. Robotic extended cholecystectomy in gallbladder cancer
Byun Y, Choi YJ, Kang JS, Han Y, Kim H, Kwon W, Jang JY
Surgical Endoscopy (2020) 34:3256–3261
Link
2428. Perioperative and oncologic outcome of robot-assisted minimally invasive (hybrid laparoscopic and robotic) pancreatoduodenectomy: based on pancreatic fistula risk score and cancer/staging matched comparison with open pancreatoduodenectomy
Kim HS, Kim H, Kwon W, Han Y, Byun Y, Kang JS, Choi YJ, Jang JY
Surg Endosc
. 2020 Apr 10.
Link